Cargando…

SIRT1: A promising therapeutic target for chronic pain

Chronic pain remains an unresolved problem. Current treatments have limited efficacy. Thus, novel therapeutic targets are urgently required for the development of more effective analgesics. An increasing number of studies have proved that sirtuin 1 (SIRT1) agonists can relieve chronic pain. In this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Fan‐He, Liu, Dai‐Qiang, Zhou, Ya‐Qun, Mei, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062570/ https://www.ncbi.nlm.nih.gov/pubmed/35396903 http://dx.doi.org/10.1111/cns.13838

Ejemplares similares

Targeting the nitric oxide/cGMP signaling pathway to treat chronic pain
por: Li, Dan-Yang, et al.
Publicado: (2022)

Targeting α7 nicotinic acetylcholine receptors for chronic pain
por: Zhou, Ya-Qun, et al.
Publicado: (2022)

SIRT6-PAI-1 axis is a promising therapeutic target in aging-related bone metabolic disruption
por: Aobulikasimu, Alkebaier, et al.
Publicado: (2023)

The Emerging Role of Quercetin in the Treatment of Chronic Pain
por: Liu, Cheng, et al.
Publicado: (2022)

Relieving Cellular Energy Stress in Aging, Neurodegenerative, and Metabolic Diseases, SIRT1 as a Therapeutic and Promising Node
por: Fang, Yang, et al.
Publicado: (2021)

Lidocaine Infusion: A Promising Therapeutic Approach for Chronic Pain
por: Kandil, Enas, et al.
Publicado: (2017)

DKK3 ameliorates neuropathic pain via inhibiting ASK-1/JNK/p-38-mediated microglia polarization and neuroinflammation
por: Zhang, Long-Qing, et al.
Publicado: (2022)

IGF/IGF-1R signal pathway in pain: a promising therapeutic target
por: Ma, Lulin, et al.
Publicado: (2023)

SIRT1: A Potential Therapeutic Target in Autoimmune Diseases
por: Shen, Pan, et al.
Publicado: (2021)

Pharmacological and Genetic Perturbation Establish SIRT5 as a Promising Target in Breast Cancer
por: Negrón Abril, Yashira L., et al.
Publicado: (2021)

Cardiac Fibrosis: Chronic Inflammatory Disease and Promising Therapeutic Target
por: Okamoto, Ryuji
Publicado: (2022)

The gastrointestinal-brain-microbiota axis: a promising therapeutic target for ischemic stroke
por: Wei, Yan-hao, et al.
Publicado: (2023)

SIRT1 and SIRT2: emerging targets in neurodegeneration
por: Donmez, Gizem, et al.
Publicado: (2013)

Dimethyl fumarate attenuates pain behaviors in osteoarthritis rats via induction of Nrf2-mediated mitochondrial biogenesis
por: Gao, Shao-Jie, et al.
Publicado: (2022)

Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor
por: Song, Xiaotian, et al.
Publicado: (2021)

PDX-1: A Promising Therapeutic Target to Reverse Diabetes
por: Zhang, Yanjiao, et al.
Publicado: (2022)

Nrf2 Activation Attenuates Chronic Constriction Injury-Induced Neuropathic Pain via Induction of PGC-1α-Mediated Mitochondrial Biogenesis in the Spinal Cord
por: Sun, Jia, et al.
Publicado: (2021)

Periostin: a promising target of therapeutical intervention for prostate cancer
por: Sun, Chuanyu, et al.
Publicado: (2011)

Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis
por: Li, Heng, et al.
Publicado: (2022)

The Critical Role of SIRT1 in Parkinson’s Disease: Mechanism and Therapeutic Considerations
por: Li, Xuan, et al.
Publicado: (2020)

Targeting Ferroptosis as a Promising Therapeutic Strategy for Ischemia-Reperfusion Injury
por: Pan, Yihang, et al.
Publicado: (2022)

Intestinal microbiota: A promising therapeutic target for hypertension
por: Sun, Dating, et al.
Publicado: (2022)

The Emerging Application of Itaconate: Promising Molecular Targets and Therapeutic Opportunities
por: Lin, Jiaqi, et al.
Publicado: (2021)

The emerging power and promise of non-coding RNAs in chronic pain
por: Zhang, Changteng, et al.
Publicado: (2022)

PKCζ as a promising therapeutic target for TNFα-induced inflammatory disorders in chronic cutaneous wounds
por: Zhang, Jian, et al.
Publicado: (2017)

Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy
por: Sun, Huiyan, et al.
Publicado: (2023)

The Critical Role of Sirt1 in Subarachnoid Hemorrhages: Mechanism and Therapeutic Considerations
por: Zhang, Zhonghua, et al.
Publicado: (2023)

SIRT2 as a Therapeutic Target for Age-Related Disorders
por: de Oliveira, Rita Machado, et al.
Publicado: (2012)

Bergenin Activates SIRT1 as a Novel Therapeutic Agent for Osteogenesis of Bone Mesenchymal Stem Cells
por: Hou, Weiduo, et al.
Publicado: (2019)

CD47 as a promising therapeutic target in oncology
por: Zhao, Hai, et al.
Publicado: (2022)

SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis
por: Zainabadi, Kayvan, et al.
Publicado: (2017)

Natural Products: A Promising Therapeutics for Targeting Tumor Angiogenesis
por: Li, Ruyi, et al.
Publicado: (2021)

Interleukin-17 as a potential therapeutic target for chronic pain
por: Jiang, Xiaojuan, et al.
Publicado: (2022)

Therapeutic promise and challenges of targeting DLL4/NOTCH1
por: Yan, Minhong
Publicado: (2011)

HMGB1: A Promising Therapeutic Target for Prostate Cancer
por: Gnanasekar, Munirathinam, et al.
Publicado: (2013)

Ficolin-1 is a promising therapeutic target for autoimmune diseases
por: Katayama, Michihito, et al.
Publicado: (2018)

SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
por: Colak, Yasar, et al.
Publicado: (2011)

New insights into Sirt1: potential therapeutic targets for the treatment of cerebral ischemic stroke
por: Tang, Hao, et al.
Publicado: (2023)

Microglia: A Potential Therapeutic Target for Sepsis-Associated Encephalopathy and Sepsis-Associated Chronic Pain
por: Li, Yi, et al.
Publicado: (2020)

Targeting Immune-Mediated Dormancy: A Promising Treatment of Cancer
por: Wang, Hao-fan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iet73353o37u33phals7gevbmn